Indivior Inc. has applied to the Drug Enforcement Administration (DEA) to be registered as an importer of certain controlled substances. They intend to import these substances in limited quantities for use in research, clinical trials, and for developing the manufacturing process of dosage forms. Comments or objections regarding this application can be submitted electronically by April 7, 2025, and requests for a hearing can also be made by that date. The DEA requires that comments be submitted through their online portal.
Simple Explanation
Indivior Inc. wants permission from the DEA to bring in small amounts of certain drugs from other countries. They need these drugs to do tests and learn how to make new medicines, and people can tell the DEA if they think this is a good or bad idea by April 7, 2025.